Sign up to save your podcasts
Or
Share Ep. 134 Alzheimer’s Disease: Update on Medications and Treatments with CEO Mark Roithmayr of the Alzheimer’s Drug Discovery Foundation (ADDF)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ep. 134 Alzheimer’s Disease: Update on Medications and Treatments with CEO Mark Roithmayr of the Alzheimer’s Drug Discovery Foundation (ADDF)
Join Travis and Mace for a conversation with Mark Roithmayr regarding recent progress in Alzheimer’s treatments plus an optimistic view for the future.
The mission of the Alzheimer's Drug Discovery Foundation is to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease. Founded in 1998 by co-chairmen Leonard A. and Ronald S. Lauder, the Alzheimer's Drug Discovery Foundation (ADDF) is the only charity solely focused on finding drugs for Alzheimer's.
Mark Roithmayr is an admired nonprofit leader with four decades of experience in both start-ups and mature organizations. As Chief Executive Officer of the ADDF, Mr. Roithmayr is responsible for steering the Foundation’s overall strategy, focus, and business operations. Since joining the ADDF in 2017, the organization has transformed dramatically in impact, scale, presence, and brand. Under his leadership, the ADDF’s revenue has increased five-fold from $17M to an excess of $90M and mission related investing has grown over 100%.
As such, Mr. Roithmayr sets the strategic vision of the ADDF and works in partnership with the Co-Founder and CSO, Howard Fillit, MD, Executive Leadership, and the Board of Governors and Overseers to advance and execute the Foundation’s mission of accelerating the discovery of drugs to prevent, treat, and cure Alzeimer’s disease and related dementias. His areas of expertise and focus include venture philanthropy, strategic planning, volunteer development, and brand-building. One of Mr. Roithmayr’s milestone accomplishments was securing Bill Gates, as well as Jeff Bezos and MacKenzie Scott, as donors to further the Foundation’s venture philanthropy efforts. Additionally, he secured a 10-figure gift from the families of Leonard and Ronald Lauder, ensuring all overhead costs will be covered at the ADDF for the next two decades.
ADDF Instagram | Website | YouTube
Trav’s Resources for Families Navigating Alzheimer’s
Thanks to our sponsors:
The Feed Instagram | Website
NeuroReserve
Use code TRAVISMACY for 15% off RELEVATE by NeuroReserve: Core Dietary Nutrients for Lifelong Brain Health
- - - - - - - - - - -
Purchase A Mile at A Time: A Father and Son’s Inspiring Alzheimer’s Journey of Love, Adventure, and Hope
Subscribe: Apple Podcast | Spotify
Check us out: Instagram | Twitter | Website | YouTube
The show is Produced and Edited by Palm Tree Pod Co.
skimo gold, endurance and life coaching with brief testimonials
View all episodes
By Travis Macy
5
7373 ratings
Join Travis and Mace for a conversation with Mark Roithmayr regarding recent progress in Alzheimer’s treatments plus an optimistic view for the future.
The mission of the Alzheimer's Drug Discovery Foundation is to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease. Founded in 1998 by co-chairmen Leonard A. and Ronald S. Lauder, the Alzheimer's Drug Discovery Foundation (ADDF) is the only charity solely focused on finding drugs for Alzheimer's.
Mark Roithmayr is an admired nonprofit leader with four decades of experience in both start-ups and mature organizations. As Chief Executive Officer of the ADDF, Mr. Roithmayr is responsible for steering the Foundation’s overall strategy, focus, and business operations. Since joining the ADDF in 2017, the organization has transformed dramatically in impact, scale, presence, and brand. Under his leadership, the ADDF’s revenue has increased five-fold from $17M to an excess of $90M and mission related investing has grown over 100%.
As such, Mr. Roithmayr sets the strategic vision of the ADDF and works in partnership with the Co-Founder and CSO, Howard Fillit, MD, Executive Leadership, and the Board of Governors and Overseers to advance and execute the Foundation’s mission of accelerating the discovery of drugs to prevent, treat, and cure Alzeimer’s disease and related dementias. His areas of expertise and focus include venture philanthropy, strategic planning, volunteer development, and brand-building. One of Mr. Roithmayr’s milestone accomplishments was securing Bill Gates, as well as Jeff Bezos and MacKenzie Scott, as donors to further the Foundation’s venture philanthropy efforts. Additionally, he secured a 10-figure gift from the families of Leonard and Ronald Lauder, ensuring all overhead costs will be covered at the ADDF for the next two decades.
ADDF Instagram | Website | YouTube
Trav’s Resources for Families Navigating Alzheimer’s
Thanks to our sponsors:
The Feed Instagram | Website
NeuroReserve
Use code TRAVISMACY for 15% off RELEVATE by NeuroReserve: Core Dietary Nutrients for Lifelong Brain Health
- - - - - - - - - - -
Purchase A Mile at A Time: A Father and Son’s Inspiring Alzheimer’s Journey of Love, Adventure, and Hope
Subscribe: Apple Podcast | Spotify
Check us out: Instagram | Twitter | Website | YouTube
The show is Produced and Edited by Palm Tree Pod Co.
skimo gold, endurance and life coaching with brief testimonials
More shows like THE TRAVIS MACY SHOW
View all
Ask a Cycling Coach Podcast - Presented by TrainerRoad
3,626 Listeners
Science Vs
12,196 Listeners
With Pace
732 Listeners
Fast Talk
305 Listeners
The Freetrail Podcast with Dylan Bowman
780 Listeners
Some Work, All Play
1,853 Listeners
Huberman Lab
29,180 Listeners
Professional Triathlon News
177 Listeners
Singletrack
948 Listeners
Choose Strong
1,415 Listeners
That Triathlon Life Podcast
551 Listeners
Nobody Asked Us with Des & Kara
1,765 Listeners
Cameron Hanes - Keep Hammering Collective
1,210 Listeners
Crack A Brew With AJW
166 Listeners
The Norwegian Method Podcast
30 Listeners